These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
736 related articles for article (PubMed ID: 11956092)
41. Increased glutathione level is not involved in enhanced bleomycin sensitivity in cisplatin-resistant 2780CP cells. Tanaka T; Kurokawa H; Matsuno K; Matsumoto S; Hayashida Y Anticancer Res; 2008; 28(5A):2663-8. PubMed ID: 19035292 [TBL] [Abstract][Full Text] [Related]
42. Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester. Nakajima T; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Abe T; Kato J; Sakon K; Naniwa Y; Tanabe H; Niitsu Y J Pharmacol Exp Ther; 2003 Sep; 306(3):861-9. PubMed ID: 12805482 [TBL] [Abstract][Full Text] [Related]
43. An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Terrier P; Townsend AJ; Coindre JM; Triche TJ; Cowan KH Am J Pathol; 1990 Oct; 137(4):845-53. PubMed ID: 1977319 [TBL] [Abstract][Full Text] [Related]
44. Brostallicin (PNU-166196)--a new DNA minor groove binder that retains sensitivity in DNA mismatch repair-deficient tumour cells. Fedier A; Fowst C; Tursi J; Geroni C; Haller U; Marchini S; Fink D Br J Cancer; 2003 Oct; 89(8):1559-65. PubMed ID: 14562032 [TBL] [Abstract][Full Text] [Related]
45. Increased expression of glutathione S-transferase gene in cis-diamminedichloroplatinum(II)-resistant variants of a Chinese hamster ovary cell line. Saburi Y; Nakagawa M; Ono M; Sakai M; Muramatsu M; Kohno K; Kuwano M Cancer Res; 1989 Dec; 49(24 Pt 1):7020-5. PubMed ID: 2479474 [TBL] [Abstract][Full Text] [Related]
46. Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa. Srivastava SK; Singhal SS; Hu X; Awasthi YC; Zimniak P; Singh SV Arch Biochem Biophys; 1999 Jun; 366(1):89-94. PubMed ID: 10334868 [TBL] [Abstract][Full Text] [Related]
47. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine. Kramer RA; Greene K; Ahmad S; Vistica DT Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359 [TBL] [Abstract][Full Text] [Related]
48. Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo. Caffrey PB; Zhang Y; Frenkel GD Anticancer Res; 1998; 18(4C):3021-5. PubMed ID: 9713503 [TBL] [Abstract][Full Text] [Related]
49. Exceptional activity of murine glutathione transferase A1-1 against (7R,8S)-dihydroxy-(9S,10R)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene-induced DNA damage in stably transfected cells. Guo J; Pan SS; Singh SV Mol Carcinog; 2003 Feb; 36(2):67-73. PubMed ID: 12557262 [TBL] [Abstract][Full Text] [Related]
50. The discovery of a new potential anticancer drug: a case history. Cozzi P Farmaco; 2003 Mar; 58(3):213-20. PubMed ID: 12620417 [TBL] [Abstract][Full Text] [Related]
51. Differential expression of glutathione S-transferases P1-1 and A1-1 at protein and mRNA levels in hepatocytes derived from human bone marrow mesenchymal stem cells. Allameh A; Esmaeli S; Kazemnejad S; Soleimani M Toxicol In Vitro; 2009 Jun; 23(4):674-9. PubMed ID: 19490842 [TBL] [Abstract][Full Text] [Related]
52. Brostallicin: a new concept in minor groove DNA binder development. Broggini M; Marchini S; Fontana E; Moneta D; Fowst C; Geroni C Anticancer Drugs; 2004 Jan; 15(1):1-6. PubMed ID: 15090736 [TBL] [Abstract][Full Text] [Related]
53. Glutathione transferase activity and isoenzyme composition in primary human breast cancers. Shea TC; Claflin G; Comstock KE; Sanderson BJ; Burstein NA; Keenan EJ; Mannervik B; Henner WD Cancer Res; 1990 Nov; 50(21):6848-53. PubMed ID: 2208151 [TBL] [Abstract][Full Text] [Related]
54. [Glutathione S transferases-pi]. Takahashi Y; Niitsu Y Gan To Kagaku Ryoho; 1994 Jun; 21(7):945-51. PubMed ID: 8002632 [TBL] [Abstract][Full Text] [Related]
55. Flow cytometric detection of glutathione S-transferase isoenzymes by quantitative immunofluorescence under nonsaturating conditions. Pifferi A; Filippini C; Capolongo L; Codegoni A; Balconi G; Ubezio P; Tagliabue G Cytometry; 1995 Jun; 20(2):134-45. PubMed ID: 7664624 [TBL] [Abstract][Full Text] [Related]
56. [Killing effect of adenovirus mediated fusion gene cytosine and deaminase uracil phosphoribosyl transferase directed by glutathione S-transferase P1 promoter on cisplatin-resistant ovarian cancer cells in vitro]. Cai LQ; Li M; Lu S; Wang HB; Wang ZH Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):478-81. PubMed ID: 15347473 [TBL] [Abstract][Full Text] [Related]
57. Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues. Albin N; Massaad L; Toussaint C; Mathieu MC; Morizet J; Parise O; Gouyette A; Chabot GG Cancer Res; 1993 Aug; 53(15):3541-6. PubMed ID: 8339260 [TBL] [Abstract][Full Text] [Related]
58. Differential sensitization of human ovarian carcinoma and mouse L1210 cells to cisplatin and melphalan by glutathione depletion. Andrews PA; Murphy MP; Howell SB Mol Pharmacol; 1986 Dec; 30(6):643-50. PubMed ID: 3785141 [TBL] [Abstract][Full Text] [Related]
59. Increased expression of cytosolic glutathione S-transferases in drug-resistant L5178Y murine lymphoblasts: chemical selectivity and molecular mechanisms. Stelmack GL; Goldenberg GJ Cancer Res; 1993 Aug; 53(15):3530-5. PubMed ID: 8101761 [TBL] [Abstract][Full Text] [Related]
60. Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomers. Benz CC; Keniry MA; Ford JM; Townsend AJ; Cox FW; Palayoor S; Matlin SA; Hait WN; Cowan KH Mol Pharmacol; 1990 Jun; 37(6):840-7. PubMed ID: 2193225 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]